Alzheimer's care shows a moment of real possibility in research

At a Radcliffe panel, experts described new research on brain lipids, tau protein, lifestyle and social factors that is expanding understanding of Alzheimer’s disease, and they said early results are promising while substantial work remains.

Researchers and clinicians gathered at a Radcliffe Institute panel to discuss recent findings that are broadening how Alzheimer’s disease is understood and studied. They noted that dementia already affects about 55 million people worldwide and that number is expected to rise significantly by 2050. Speakers described continued work on the long-studied amyloid pathway, including an approved drug that reduces amyloid plaques but slows rather than reverses cognitive decline. Panelists also highlighted other lines of inquiry such as lipid (fat) metabolism in the brain, tau protein behavior, lifestyle patterns, and social influences on risk. Key facts: - The recently approved drug donanemab is reported to reduce amyloid beta plaques in the brain but has been shown to slow cognitive decline rather than reverse it. - Leyla Akay and colleagues discussed a focus on lipid metabolism, noting the APOE4 gene’s link to lipid transport and early laboratory work on GSK3 beta that reduced lipid buildup and improved myelination in models. - Research on tau protein includes efforts to understand how some neurons can unravel and clear tau tangles, which researchers view as a potential avenue for future therapies. - Speakers reported links between lifestyle and social factors and Alzheimer’s risk, including diet patterns, physical activity (with modest walking showing measurable associations), and population disparities such as higher reported risk among Black and Hispanic Americans compared with non-Hispanic white Americans. Summary: Panelists said the diversity of approaches—from molecular studies of lipids and tau to population research on diet, activity, and social drivers—is widening the scientific view of Alzheimer’s disease. Early findings were described as promising, but speakers emphasized that substantial research and validation remain and specific research directions are undetermined at this time.